The world’s population is aging at an unprecedented pace. According to WHO’s October 2024 report, the number of people aged 60 and older surpassed children under five for the first time in 2020. By ...

Dr. Mehmet Oz holds millions of dollars worth of shares in health insurance, fertility, pharmaceutical and vitamin companies ...

Our health care system is in critical condition, and it’s core sickness is monopolies,” she said in a virtual event ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each ...

AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...

Buster Posey and Bob Melvin set the tone for the San Francisco Giants’ 2025 MLB season with similar messages on the first full practice of spring training.

Dividend-growth stocks offer steady income and long-term value. With the Fed holding rates and inflation expected to ease, ...

The discovery of this hormone paved the way for Ozempic, making the Gila monster an enormously profitable gift to modern ...

AbbVie (NYSE: ABBV) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, ...

The local soccer season kicks off, there’s a do-or-die rugby clash, and it’s crunch time in MacHale Park as Tyrone come to ...

We recently compiled a list of the Top 10 Stocks to Buy According to Lee Munder Capital Group. In this article, we are going ...